UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000011230
Receipt No. R000013157
Scientific Title Phase II Clinical trial of personalized peptide vaccine for patients with maligant tumors (gastrointestinal cancers, hepato-biliary-pancreatic cancers, thoracic malignant tumors, non-epithelial malignant tumors, genitourinary cancers, gynecological cancers, breast cancers, and rare cancers) - Effect of extended interval dosing on immune responses -
Date of disclosure of the study information 2013/07/23
Last modified on 2019/12/06 14:54:54

No. Disposal Last modified on Item of update
1 Insert 2013/07/19 15:36:42
2 Update 2014/07/14 17:13:44 Email
3 Update 2014/12/12 12:22:15
Key inclusion criteria
Key inclusion criteria
4 Update 2019/01/07 11:08:22 Recruitment status
5 Update 2019/12/06 14:54:54 Recruitment status
Date of IRB
Last follow-up date

Contact us.